Eugeen Vanmechelen

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Cerebrospinal Fluid

Blood Brain Barrier

Cognitive Decline

Top Venues

Nature medicine

Alzheimer's research & therapy

Biomarker research

This page only lists publications with an associated author ORCID identifier.

Publications

Betty M Tijms, Ellen M Vromen, Olav Mjaavatten, Henne Holstege, Lianne M Reus, Sven J Van der Lee, Kirsten E J Wesenhagen, Luigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccolo' Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, Frederik Barkhof, Yolande A L Pijnenburg, Wiesje Maria van der Flier, Charlotte E Teunissen, Frode S Berven, Pieter Jelle Visser
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. Nature aging (2024)
Betty M Tijms, Ellen M Vromen, Olav Mjaavatten, Henne Holstege, Lianne M Reus, Sven J Van der Lee, Kirsten E J Wesenhagen, Luigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccolo' Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, Frederik Barkhof, Yolande A L Pijnenburg, Wiesje Maria van der Flier, Charlotte E Teunissen, Frode S Berven, Pieter Jelle Visser
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. Nature aging 4 (1) (2024)
Betty M Tijms, Ellen M Vromen, Olav Mjaavatten, Henne Holstege, Lianne M Reus, Sven J Van der Lee, Kirsten E J Wesenhagen, Luigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccolo' Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, Frederik Barkhof, Yolande A L Pijnenburg, Wiesje Maria van der Flier, Charlotte E Teunissen, Frode S Berven, Pieter Jelle Visser
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. Nature aging 4 (1) (2024)
Betty M Tijms, Ellen M Vromen, Olav Mjaavatten, Henne Holstege, Lianne M Reus, Sven J Van der Lee, Kirsten E J Wesenhagen, Luigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccolo' Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, Frederik Barkhof, Yolande A L Pijnenburg, Wiesje Maria van der Flier, Charlotte E Teunissen, Frode S Berven, Pieter Jelle Visser
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. Nature aging 4 (1) (2024)
Betty M Tijms, Ellen M Vromen, Olav Mjaavatten, Henne Holstege, Lianne M Reus, Sven J Van der Lee, Kirsten E J Wesenhagen, Luigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccolo' Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, Frederik Barkhof, Yolande A L Pijnenburg, Wiesje Maria van der Flier, Charlotte E Teunissen, Frode S Berven, Pieter Jelle Visser
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. Nature aging (2024)
Betty M Tijms, Ellen M Vromen, Olav Mjaavatten, Henne Holstege, Lianne M Reus, Sven J Van der Lee, Kirsten E J Wesenhagen, Luigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccolo' Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, Frederik Barkhof, Yolande A L Pijnenburg, Wiesje Maria van der Flier, Charlotte E Teunissen, Frode S Berven, Pieter Jelle Visser
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. Nature aging 4 (1) (2024)
Julie Goossens, Alba Cervantes González, Nele Dewit, Laia Lidón, Juan Fortea, Daniel Alcolea, Alberto Lleó, Olivia Belbin, Eugeen Vanmechelen
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum. Alzheimer's research & therapy 15 (1) (2023)
Steffi De Meyer, Jeroen Vanbrabant, Jolien M Schaeverbeke, Mariska Reinartz, Emma Susanne Luckett, Patrick Dupont, Koen Van Laere, Erik Stoops, Eugeen Vanmechelen, Koen Poesen, Rik Vandenberghe
Phospho-specific plasma p-tau181 assay detects clinical as well as asymptomatic Alzheimer's disease. Annals of clinical and translational neurology 9 (5) (2022)
Marta Milà-Alomà, Nicholas J Ashton, Mahnaz Shekari, Gemma Salvadó, Paula Ortiz-Romero, Laia Montoliu-Gaya, Andrea L Benedet, Jonathan M Schott, Juan Lantero-Rodriguez, Eugeen Vanmechelen, Theresa A Day, Armand González-Escalante, Gonzalo Sánchez-Benavides, Carolina Minguillon, Karine Fauria, José Luis Molinuevo, Jeffrey L Dage, Henrik Zetterberg, Juan Domingo Gispert, Marc Suarez-Calvet, Kaj Blennow
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease. Nature medicine 28 (9) (2022)
Nicholas J Ashton, Shorena Janelidze, Niklas Mattsson-Carlgren, Alexa Pichet Binette, Olof Strandberg, Wagner S Brum, Jonathan M Schott, Fernándo González-Ortiz, Guglielmo Di Molfetta, Francisco J Meda, Erin M Jonaitis, Rebecca Langhough Koscik, Karly Alex Cody, Tobey J Betthauser, Yan Li, Eugeen Vanmechelen, Sebastian Palmqvist, Erik Stomrud, Randell J Bateman, Henrik Zetterberg, Sterling C Johnson, Kaj Blennow, Oskar Hansson
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring. Nature medicine (2022)
Shreyasee Das, Nele Dewit, Dirk Jacobs, Yolande A L Pijnenburg, Sjors G J G In 't Veld, Salomé Coppens, Milena Quaglia, Christophe Hirtz, Charlotte E Teunissen, Eugeen Vanmechelen
A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration. International journal of molecular sciences 23 (13) (2022)
Katharina Waury, Eline A J Willemse, Eugeen Vanmechelen, Henrik Zetterberg, Charlotte E Teunissen, Sanne Abeln
Bioinformatics tools and data resources for assay development of fluid protein biomarkers. Biomarker research 10 (1) (2022)
Antoine Leuzy, Shorena Janelidze, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Dirk Jacobs, Claudia Cicognola, Erik Stomrud, Eugeen Vanmechelen, Jeffrey L Dage, Oskar Hansson
Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays. Neurology 97 (17) (2021)
Yann Fichou, Youssra K Al-Hilaly, François Devred, Caroline Smet-Nocca, Philipp O Tsvetkov, Joke Verelst, Joris Winderickx, Nick Geukens, Eugeen Vanmechelen, Audrey Perrotin, Louise Serpell, Bernard J Hanseeuw, Miguel Medina, Luc Buee, Isabelle Landrieu
The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention? Acta neuropathologica communications 7 (1) (2019)
Ann De Vos, Maria Bjerke, Raf Brouns, Naomi De Roeck, Dirk Jacobs, Lien Van den Abbeele, Kaat Guldolf, Henrik Zetterberg, Kaj Blennow, Sebastiaan Engelborghs, Eugeen Vanmechelen
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke. BMC neurology 17 (1) (2017)